Electromed, Inc. (ELMD)
USD 27.0
(-3.98%)
USD 27.0
(-3.98%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 87 Thousand USD | -45.96% |
| 2023 | 161 Thousand USD | 292.68% |
| 2022 | 41 Thousand USD | -52.87% |
| 2021 | 87 Thousand USD | 7.15% |
| 2020 | 81.19 Thousand USD | 80.21% |
| 2019 | 45.05 Thousand USD | -95.91% |
| 2018 | 1.1 Million USD | -4.08% |
| 2017 | 1.14 Million USD | -4.54% |
| 2016 | 1.2 Million USD | -3.9% |
| 2015 | 1.25 Million USD | -3.57% |
| 2014 | 1.29 Million USD | -6.65% |
| 2013 | 1.38 Million USD | -59.26% |
| 2012 | 3.41 Million USD | -9.93% |
| 2011 | 3.78 Million USD | -9.78% |
| 2010 | 4.19 Million USD | 17.97% |
| 2009 | 3.55 Million USD | 14.89% |
| 2008 | 3.09 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 87 Thousand USD | -45.96% |
| 2024 Q1 | 68 Thousand USD | -57.76% |
| 2024 Q2 | 49 Thousand USD | -27.94% |
| 2024 Q3 | 31 Thousand USD | -36.73% |
| 2024 Q4 | 87 Thousand USD | 180.65% |
| 2023 Q3 | 30 Thousand USD | -9.09% |
| 2023 Q2 | 33 Thousand USD | -10.81% |
| 2023 Q1 | 37 Thousand USD | -9.76% |
| 2023 Q4 | 161 Thousand USD | 436.67% |
| 2023 FY | 161 Thousand USD | 292.68% |
| 2022 Q2 | 47 Thousand USD | -60.5% |
| 2022 Q4 | 41 Thousand USD | -4.65% |
| 2022 Q1 | 119 Thousand USD | 36.78% |
| 2022 FY | 41 Thousand USD | -52.87% |
| 2022 Q3 | 43 Thousand USD | -8.51% |
| 2021 Q3 | 59.7 Thousand USD | 1419.52% |
| 2021 Q4 | 87 Thousand USD | 45.72% |
| 2021 Q1 | 6001.00 USD | -33.32% |
| 2021 Q2 | 3929.00 USD | -34.53% |
| 2021 FY | 87 Thousand USD | 7.15% |
| 2020 Q4 | 9000.00 USD | -63.0% |
| 2020 FY | 81.19 Thousand USD | 80.21% |
| 2020 Q3 | 24.32 Thousand USD | -38.62% |
| 2020 Q2 | 39.62 Thousand USD | -52.08% |
| 2020 Q1 | 82.69 Thousand USD | 461.15% |
| 2019 Q1 | 1.08 Million USD | -1.08% |
| 2019 FY | 45.05 Thousand USD | -95.91% |
| 2019 Q4 | 14.73 Thousand USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | -100.0% |
| 2018 Q4 | 1.1 Million USD | -1.06% |
| 2018 FY | 1.1 Million USD | -4.08% |
| 2018 Q3 | 1.11 Million USD | -1.06% |
| 2018 Q2 | 1.12 Million USD | -1.03% |
| 2018 Q1 | 1.13 Million USD | -0.99% |
| 2017 FY | 1.14 Million USD | -4.54% |
| 2017 Q1 | 1.18 Million USD | -1.77% |
| 2017 Q2 | 1.17 Million USD | -0.9% |
| 2017 Q3 | 1.15 Million USD | -0.98% |
| 2017 Q4 | 1.14 Million USD | -0.97% |
| 2016 Q4 | 1.2 Million USD | -1.02% |
| 2016 Q2 | 1.22 Million USD | -0.98% |
| 2016 FY | 1.2 Million USD | -3.9% |
| 2016 Q1 | 1.23 Million USD | -0.95% |
| 2016 Q3 | 1.21 Million USD | -1.01% |
| 2015 FY | 1.25 Million USD | -3.57% |
| 2015 Q4 | 1.25 Million USD | -0.93% |
| 2015 Q3 | 1.26 Million USD | -0.93% |
| 2015 Q1 | 1.28 Million USD | -0.87% |
| 2015 Q2 | 1.27 Million USD | -0.9% |
| 2014 Q2 | 1.31 Million USD | -3.71% |
| 2014 FY | 1.29 Million USD | -6.65% |
| 2014 Q4 | 1.29 Million USD | -0.85% |
| 2014 Q3 | 1.3 Million USD | -0.85% |
| 2014 Q1 | 1.37 Million USD | -1.38% |
| 2013 Q3 | 1.96 Million USD | -2.76% |
| 2013 Q4 | 1.38 Million USD | -29.34% |
| 2013 FY | 1.38 Million USD | -59.26% |
| 2013 Q1 | 3.3 Million USD | -3.22% |
| 2013 Q2 | 2.02 Million USD | -38.74% |
| 2012 Q3 | 3.52 Million USD | -3.02% |
| 2012 Q1 | 3.67 Million USD | -2.9% |
| 2012 FY | 3.41 Million USD | -9.93% |
| 2012 Q4 | 3.41 Million USD | -3.14% |
| 2012 Q2 | 3.63 Million USD | -1.26% |
| 2011 Q2 | 3.5 Million USD | -2.37% |
| 2011 Q4 | 3.78 Million USD | 11.51% |
| 2011 Q3 | 3.39 Million USD | -3.18% |
| 2011 Q1 | 3.59 Million USD | -14.42% |
| 2011 FY | 3.78 Million USD | -9.78% |
| 2010 Q4 | 4.19 Million USD | 11.17% |
| 2010 Q3 | 3.77 Million USD | 0.0% |
| 2010 FY | 4.19 Million USD | 17.97% |
| 2009 FY | 3.55 Million USD | 14.89% |
| 2009 Q4 | 3.55 Million USD | 0.0% |
| 2008 FY | 3.09 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Myomo, Inc. | 601.3 Thousand USD | 85.531% |
| Senseonics Holdings, Inc. | 47.77 Million USD | 99.818% |
| Catheter Precision, Inc. | 372 Thousand USD | 76.613% |
| Xtant Medical Holdings, Inc. | 23.55 Million USD | 99.631% |